Lombard Odier Asset Management Europe Ltd Purchases 23,239 Shares of Zoetis Inc. $ZTS

Lombard Odier Asset Management Europe Ltd grew its position in shares of Zoetis Inc. (NYSE:ZTS) by 33.3% during the first quarter, Holdings Channel reports. The institutional investor owned 93,097 shares of the company’s stock after purchasing an additional 23,239 shares during the quarter. Lombard Odier Asset Management Europe Ltd’s holdings in Zoetis were worth $11,005,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. J. Stern & Co. LLP lifted its holdings in Zoetis by 12,431.2% during the fourth quarter. J. Stern & Co. LLP now owns 24,069,492 shares of the company’s stock valued at $3,028,423,000 after purchasing an additional 23,877,416 shares during the last quarter. Norges Bank bought a new position in Zoetis during the fourth quarter worth about $734,425,000. Vanguard Group Inc. increased its stake in shares of Zoetis by 12.9% in the fourth quarter. Vanguard Group Inc. now owns 47,780,974 shares of the company’s stock worth $6,011,802,000 after purchasing an additional 5,474,210 shares in the last quarter. Ruane Cunniff & Goldfarb L.P. purchased a new position in shares of Zoetis in the first quarter worth about $286,660,000. Finally, Van ECK Associates Corp raised its position in shares of Zoetis by 269.0% in the fourth quarter. Van ECK Associates Corp now owns 2,387,059 shares of the company’s stock valued at $300,340,000 after purchasing an additional 1,740,113 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ZTS. TD Cowen lowered their target price on shares of Zoetis from $150.00 to $104.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. Wall Street Zen lowered Zoetis from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Argus reiterated a “hold” rating on shares of Zoetis in a research report on Wednesday, May 27th. Stifel Nicolaus decreased their price objective on Zoetis from $95.00 to $85.00 and set a “hold” rating on the stock in a research note on Friday, June 26th. Finally, JPMorgan Chase & Co. dropped their price objective on Zoetis from $190.00 to $130.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Zoetis has a consensus rating of “Hold” and a consensus target price of $118.33.

Zoetis Price Performance

Shares of NYSE:ZTS opened at $77.37 on Monday. The company has a 50 day moving average of $77.05 and a 200 day moving average of $102.33. The stock has a market cap of $32.44 billion, a P/E ratio of 12.83, a P/E/G ratio of 1.21 and a beta of 0.75. Zoetis Inc. has a 12 month low of $71.47 and a 12 month high of $160.48. The company has a current ratio of 3.15, a quick ratio of 1.91 and a debt-to-equity ratio of 2.80.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, May 7th. The company reported $1.53 EPS for the quarter, missing the consensus estimate of $1.60 by ($0.07). The firm had revenue of $2.26 billion during the quarter, compared to the consensus estimate of $2.30 billion. Zoetis had a net margin of 27.80% and a return on equity of 66.85%. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.48 earnings per share. Zoetis has set its FY 2026 guidance at 6.850-7.000 EPS. As a group, sell-side analysts forecast that Zoetis Inc. will post 6.87 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Investors of record on Monday, July 20th will be paid a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.7%. Zoetis’s dividend payout ratio (DPR) is currently 35.16%.

Insider Buying and Selling

In other Zoetis news, Director Paul Bisaro purchased 2,000 shares of the stock in a transaction on Wednesday, May 13th. The shares were purchased at an average price of $75.88 per share, with a total value of $151,760.00. Following the acquisition, the director directly owned 27,862 shares in the company, valued at approximately $2,114,168.56. The trade was a 7.73% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Frank A. Damelio purchased 6,650 shares of the company’s stock in a transaction dated Wednesday, May 13th. The shares were acquired at an average price of $75.39 per share, with a total value of $501,343.50. Following the transaction, the director owned 21,458 shares in the company, valued at approximately $1,617,718.62. The trade was a 44.91% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 11,650 shares of company stock worth $886,384 over the last ninety days. 0.22% of the stock is owned by corporate insiders.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.